{"id":62786,"date":"2026-03-13T16:06:39","date_gmt":"2026-03-13T15:06:39","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/"},"modified":"2026-03-13T16:06:39","modified_gmt":"2026-03-13T15:06:39","slug":"access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/","title":{"rendered":"ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter to Ambulatory Surgery Centers"},"content":{"rendered":"
\n

\nAgreement will expand access to next-generation technology for cardiac electrophysiology procedures<\/b><\/p>\n

NEW YORK–(BUSINESS WIRE)–ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter in ambulatory surgery centers (ASCs) across the United States. The agreement is designed to help physician-led ASCs gain earlier access to next-generation technology for treatment of cardiac arrhythmias in the ASC setting.<\/p>\n

<\/a>
<\/a><\/p>\n

\nPulsed field ablation (PFA) is emerging as one of the most important advances in the treatment of atrial fibrillation. In the ASC setting, successful adoption depends not only on the promise of the technology itself, but on whether it can be implemented with the right workflow alignment, efficiency and strategic support. ACCESS GPO is partnering with Medtronic to help ASCs meet that challenge.<\/p>\n

\nAs a physician-led group purchasing organization focused on electrophysiology in ASCs, ACCESS GPO chose the Affera system and Sphere-9 catheter for its safety, efficacy and versatility for patients. Sphere-9 is an all-in-one, high density mapping and dual energy (radiofrequency and pulsed field) ablation catheter that is being rapidly adopted by electrophysiologists in the U.S. and around the world. In addition to its highly favorable safety and efficacy profile, Sphere-9 provides improved lab efficiency and workflow for physicians to address a variety of different arrhythmias, making it an excellent choice for the ASC environment.<\/p>\n

\n\u201cThis agreement is about broadening the reach of a new and safer treatment and ensuring independent, physician-led ASCs have a real opportunity to participate in the future of ablation,\u201d said Dr. Vivek Reddy, Director of Cardiac Arrhythmia Services at The Mount Sinai Fuster Heart Hospital and the Mount Sinai Health System in New York City.<\/i> \u201cAs innovation accelerates, physician-led centers should not have to wait for access, nor should the patients they treat.\u201d<\/p>\n

\n\u201cPhysician governance of partnerships in ASCs is essential to ensure the focus remains on critical success factors such as clinical quality and sustainable adoption while also providing the best treatment for patients,\u201d said Dr. Arash Aryana, Medical Director of Cardiovascular Services and the Cardiac Electrophysiology Laboratory at Mercy General Hospital in Sacramento, California. \u201cOur goal is to support and foster strong physician governance as ASCs expand and evolve.\u201d<\/p>\n

\n\u201cWith the rise of PFA, this is an exciting time in electrophysiology with safer and more efficient technologies available,\u201d said Dr. Vijay Swarup, Executive Medical Director of Cardiac Electrophysiology at Arizona Heart Rhythm Center in Phoenix, Arizona \u201cWith ACCESS GPO, we are enabling physician-led ASCs to gain access to this innovation sooner, with the support needed for successful adoption.\u201d<\/p>\n

\nAbout ACCESS GPO<\/b><\/p>\n

\nACCESS GPO is a physician-led group purchasing organization focused on supporting ambulatory surgery centers, with a particular emphasis on cardiac electrophysiology. The organization works to improve access to advanced technologies, strengthen procedural economics, and preserve physician-led governance as more complex cardiovascular care moves into the outpatient setting.<\/p>\n

\nBy building strategic vendor relationships around those principles, ACCESS GPO aims to strengthen the long-term foundation for advanced cardiac electrophysiology in ASCs. The organization believes that physician-led outpatient centers should be able to deliver high-level electrophysiology care without giving up control over governance, economics, or clinical standards.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:
\n
Jasmine Kaur, MBBS, MPH
\n
Media Relations
\n
ACCESS GPO
\n
jkaur@accesspartner.org<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Agreement will expand access to next-generation technology for cardiac electrophysiology procedures NEW YORK–(BUSINESS WIRE)–ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter in ambulatory surgery centers (ASCs) across the United States. The agreement is designed to help physician-led ASCs gain earlier … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62786","6":"format-standard","7":"category-industry"},"yoast_head":"\nACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter to Ambulatory Surgery Centers - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter to Ambulatory Surgery Centers - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Agreement will expand access to next-generation technology for cardiac electrophysiology procedures NEW YORK–(BUSINESS WIRE)–ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter in ambulatory surgery centers (ASCs) across the United States. The agreement is designed to help physician-led ASCs gain earlier ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-13T15:06:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260312854786\/en\/2746453\/22\/ACCESS_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter to Ambulatory Surgery Centers\",\"datePublished\":\"2026-03-13T15:06:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/\"},\"wordCount\":559,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260312854786\\\/en\\\/2746453\\\/22\\\/ACCESS_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/\",\"name\":\"ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter to Ambulatory Surgery Centers - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260312854786\\\/en\\\/2746453\\\/22\\\/ACCESS_Logo.jpg\",\"datePublished\":\"2026-03-13T15:06:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260312854786\\\/en\\\/2746453\\\/22\\\/ACCESS_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260312854786\\\/en\\\/2746453\\\/22\\\/ACCESS_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter to Ambulatory Surgery Centers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter to Ambulatory Surgery Centers - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/","og_locale":"en_US","og_type":"article","og_title":"ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter to Ambulatory Surgery Centers - Pharma Trend","og_description":"Agreement will expand access to next-generation technology for cardiac electrophysiology procedures NEW YORK–(BUSINESS WIRE)–ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter in ambulatory surgery centers (ASCs) across the United States. The agreement is designed to help physician-led ASCs gain earlier ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/","og_site_name":"Pharma Trend","article_published_time":"2026-03-13T15:06:39+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260312854786\/en\/2746453\/22\/ACCESS_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter to Ambulatory Surgery Centers","datePublished":"2026-03-13T15:06:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/"},"wordCount":559,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260312854786\/en\/2746453\/22\/ACCESS_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/","url":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/","name":"ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter to Ambulatory Surgery Centers - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260312854786\/en\/2746453\/22\/ACCESS_Logo.jpg","datePublished":"2026-03-13T15:06:39+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260312854786\/en\/2746453\/22\/ACCESS_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260312854786\/en\/2746453\/22\/ACCESS_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/access-gpo-announces-preferred-strategic-commercial-agreement-to-provide-affera-mapping-and-ablation-system-with-sphere-9-catheter-to-ambulatory-surgery-centers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ACCESS GPO Announces Preferred Strategic Commercial Agreement to Provide Affera\u2122 Mapping and Ablation System with Sphere-9\u2122 Catheter to Ambulatory Surgery Centers"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62786","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62786"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62786\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62786"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}